Autologous bone marrow-derived mesenchymal stem cells (BM-MSC) for intradiscal injection
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous bone marrow-derived mesenchymal stem cells (BM-MSC) for intradiscal injection, covering 2025-05-25 to 2025-05-25. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy of Intradiscal Injection of Autologous BM-MSC in Worker Patients Affected by Chronic LBP Due to Multilevel IDD [Phase 2]